(Date:5/13/2008)... HARBIN, China, May 13 /Xinhua-PRNewswire-FirstCa...oard: CSKI), a manufacturer, marketer and,distribu...oducts in China,today announced that it will cond... May 15, 2008 to discuss its first quarter 2008 fi...man, CEO and Director of China Sky One,Medical, In...
(Date:5/13/2008)...ildbearing had no such benefit if baby was bottle-...13 (HealthDay News) -- Women who breast feed for m...arthritis (RA) by half, according to a new Swedish...g children but not breast-feeding offered women no...contraceptives also failed to reduce the risk of R...
(Date:5/13/2008)...NEW YORK (May 13, 2008) -- Promising results from ...ell Medical Center physician-scientists show that ... the progression of Batten disease, or Late Infant..., genetic, degenerative neurological disorder that... to 12. , The clinical trial found that the pro...
(Date:5/13/2008)... SALT LAKE CITY, May 13 /PRNewswire/ -- Paramed S...ent of their marine-grade Mobility Offers,Versatil...chair to oil and,gas platform operators in the Gul...platforms will enable the safe and timely evacuati...atform., Paramed developed the dual-track MOV in ...
Breaking Medicine News(10 mins):Health News:China Sky One Medical, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Breast-feeding Might Shield Women From Rheumatoid Arthritis 2Health News:NYP/Weill Cornell gene therapy clinical trial yields promising results for Batten disease 2... tortillas probably doesn't come to mind. But a Ka...with ways to add fiber to the foods we love witho.... Sajid Alavi is an assistant professor of grain ...ollege of Agriculture. His expertise is in extrusi...
...otting protein found in circulating blood, has bee...ystem neuronal cells , a process that is necessary...umatic injury. The findings by researchers at the...CSD) School of Medicine, may explain why the human...
...12 weeks pregnant with rocker boyfriend Joel Madde...fe" star, is reported to have shared the joyful ne...cluding Mischa Barton. However, she is neither co...r pregnancy to the media. Apart from her impendin...
...covered from the bottom of a two-kilometre thick i...s much warmer at some point during the last Ice Ag...e trees, plants and insects of a boreal forest est...,000 years old. Previously, the youngest evidence ...
Other Medicine News:Health News:Snack Foods Fortified With Fiber 2Health News:Fibrinogen may Inhibit Spinal Cord Regeneration 2(Date:5/12/2008)... their function like a radio dial, not an on/off,l...une disease may develop,late in life, MEMPHIS, ...e Children,s,Research Hospital study shows that T ... use simple on/off switches to govern the cellular...nction. Rather, they,possess sophisticated molecul...
(Date:5/12/2008)... 12 /- Arbios Systems, Inc....he Company has received,approval from the U.S. Foo...ional Device Exemption ("IDE") to begin the pivota...real (outside the body) liver assist,device for bl... from,chronic liver disease., "We are pleased to ...
(Date:5/12/2008)...rt 3 Demonstrated Improvement in T-Cell Responses ...al of HspE7, SAN DIEGO, May 12 /PRNewswire-FirstC...: NVN) today announced positive immunological data...ical trial of its lead product,candidate, HspE7, i..., or,CIN, a precursor to cervical cancer. HPV 16 E...
(Date:5/9/2008).../PRNewswire-USNewswire/ -- Many strong acting pain...an include nausea and,vomiting with short-term use...symptoms can lead patients to discontinue treatmen...ent for physicians. The novel investigational,medi...ic, provided pain,relief for patients with fewer g...
Breaking Medicine Technology:St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 6New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4Registry unveils real world data on novel excel stent 15505 1Registry unveils real world data on novel excel stent 15505 2Study finds support for PCI in unprotected left main disease 15501 1Study finds support for PCI in unprotected left main disease 15501 2Study finds support for PCI in unprotected left main disease 15501 3Response Biomedical Corporation Reports 2007 Financial Results 15498 1Response Biomedical Corporation Reports 2007 Financial Results 15498 2Response Biomedical Corporation Reports 2007 Financial Results 15498 3Response Biomedical Corporation Reports 2007 Financial Results 15498 4Response Biomedical Corporation Reports 2007 Financial Results 15498 5China Medicine Corporation to Present at Brean Murray Carret 26 Co Mainland China Investor Tour 15494 1China Medicine Corporation to Present at Brean Murray Carret 26 Co Mainland China Investor Tour 15494 2... /PRNewswire-FirstCall/ --,Replidyne, Inc. announc...al trial using faropenem medoxomil (faropenem) in ...a common infection of the,middle ear. Initial anal...mary objective to show that faropenem was effectiv... to permit the dose,selection for Phase III trials...
...mplete Response or Reduction of,Lesion Size by Mor...007 /PRNewswire-FirstCall/ - Nventa,Biopharmaceuti...of,positive results from a clinical trial examinin...an investigational therapeutic,vaccine for human p...h the highest grade of cervical dysplasia (CIN III...
Other Medicine Technology:Replidyne Phase II Pediatric Trial Meets Primary Objective 2Replidyne Phase II Pediatric Trial Meets Primary Objective 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: